Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4405 results

Sort By:

Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)

Study ID: NCT06651957
Start Date: 2024-11-30
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Biospecimen Collection

Questionnaires

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Study ID: NCT04199026
Start Date: 2025-01-31
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

Doxorubicin

Doxorubicin Hydrochloride

Drug Delivery Microdevice

Everolimus

Ganitumba

Ifosfamide

Irinotecan

Pazopanib

Polyethylene Glycol

Temozolomide

Temsirolimus

Therapeutic Conventional Surgery

Vincristine

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Guanfacine for Hyperactivity in Children with Down Syndrome (HYPEbeGONE_DS)

Study ID: NCT06042257
Start Date: 2024-12
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Guanfacine Hydrochloride Immediate Release

Placebo

Sponsor

Rachel G. Greenberg, MD, MB, MHS

Source: clinicaltrials.gov

Share:
Add to list

Vancomycin Dose Optimization in Obesity

Study ID: NCT06601257
Start Date: 2025-01-05
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Vancomycin (IV)

Sponsor

University of Michigan

Source: clinicaltrials.gov

Share:
Add to list

Skeletal Muscle Ultrasonography in Detection of Malnutrition

Study ID: NCT06382766
Start Date: 2025-03
End Date: 2026-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Skeletal Muscle Ultrasonography

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Study ID: NCT06641466
Start Date: 2024-12-24
End Date: 2026-09-13
Study Type

Interventional

Study Phase

Phase3

No. of Participants

723

Intervention / Treatment

They were retrieving

Placebo Comparator

Standard of Care

They were retrieving

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate Safety and Effectiveness of Pancreatic Cells Derived From Pigs (OPF-310) in Patients With Type 1 Diabetes Mellitus

Study ID: NCT06575426
Start Date: 2024-12-28
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

13

Intervention / Treatment

OPF-310

Sponsor

Otsuka Pharmaceutical Factory, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation-2 (TELSTAR-2)

Study ID: NCT06549426
Start Date: 2025-01
End Date: 2030-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

anti-seizure medication + sedative agent(s)

Sponsor

University of Twente

Source: clinicaltrials.gov

Share:
Add to list

LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients

Study ID: NCT06657326
Start Date: 2024-12
End Date: 2030-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

444

Intervention / Treatment

BioFreedom™ Ultra cobalt-chromium Biolimus A9™-coated stent

BioFreedom™ stainless steel Biolimus A9™-coated stent

Sponsor

Biosensors Europe SA

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients

Study ID: NCT03686657
Start Date: 2025-10-10
End Date: 2029-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

115

Intervention / Treatment

Metformin

Val, Cel and Met XR Low

Val, Cel and Met XR High

Sponsor

ARKAY Therapeutics

Source: clinicaltrials.gov

Share:
Add to list